Canaccord raised the firm’s price target on UiPath to $21 from $19 and keeps a Buy rating on the shares. The firm said Q2 results were encouraging with a nice in-quarter beat and ongoing operating leverage leading to a solid raise to FY EBIT guidance as well.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PATH: